These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1713587)

  • 1. Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase.
    Cohen KA; Hopkins J; Ingraham RH; Pargellis C; Wu JC; Palladino DE; Kinkade P; Warren TC; Rogers S; Adams J
    J Biol Chem; 1991 Aug; 266(22):14670-4. PubMed ID: 1713587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatography and photoaffinity crosslinking to explore the binding environment of nevirapine to reverse transcriptase of human immunodeficiency virus.
    Palladino DE; Hopkins JL; Ingraham RH; Warren TC; Kapadia SR; Van Moffaert GJ; Grob PM; Stevenson JM; Cohen KA
    J Chromatogr A; 1994 Jul; 676(1):99-112. PubMed ID: 7522840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug.
    Grob PM; Wu JC; Cohen KA; Ingraham RH; Shih CK; Hargrave KD; McTague TL; Merluzzi VJ
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):145-52. PubMed ID: 1371691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 reverse transcriptase and virus replication by a non-nucleoside dipyridodiazepinone BI-RG-587 (Nevirapine).
    Skoog MT; Hargrave KD; Miglietta JJ; Kopp EB; Merluzzi VJ
    Med Res Rev; 1992 Jan; 12(1):27-40. PubMed ID: 1371177
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site.
    Wu JC; Warren TC; Adams J; Proudfoot J; Skiles J; Raghavan P; Perry C; Potocki I; Farina PR; Grob PM
    Biochemistry; 1991 Feb; 30(8):2022-6. PubMed ID: 1705436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptases display reversed sensitivity to nonnucleoside analog inhibitors.
    Shih CK; Rose JM; Hansen GL; Wu JC; Bacolla A; Griffin JA
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9878-82. PubMed ID: 1719542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steady state kinetics and inhibition of HIV-1 reverse transcriptase by a non-nucleoside dipyridodiazepinone, BI-RG-587, using a heteropolymeric template.
    Kopp EB; Miglietta JJ; Shrutkowski AG; Shih CK; Grob PM; Skoog MT
    Nucleic Acids Res; 1991 Jun; 19(11):3035-9. PubMed ID: 1711678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.
    Richman D; Shih CK; Lowy I; Rose J; Prodanovich P; Goff S; Griffin J
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11241-5. PubMed ID: 1722324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors.
    Condra JH; Emini EA; Gotlib L; Graham DJ; Schlabach AJ; Wolfgang JA; Colonno RJ; Sardana VV
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1441-6. PubMed ID: 1380789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid substitutions in HIV-1 reverse transcriptase with corresponding residues from HIV-2. Effect on kinetic constants and inhibition by non-nucleoside analogs.
    Bacolla A; Shih CK; Rose JM; Piras G; Warren TC; Grygon CA; Ingraham RH; Cousins RC; Greenwood DJ; Richman D
    J Biol Chem; 1993 Aug; 268(22):16571-7. PubMed ID: 7688367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587.
    Tramontano E; Cheng YC
    Biochem Pharmacol; 1992 Mar; 43(6):1371-6. PubMed ID: 1373283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
    Smerdon SJ; Jäger J; Wang J; Kohlstaedt LA; Chirino AJ; Friedman JM; Rice PA; Steitz TA
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3911-5. PubMed ID: 7513427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
    Merluzzi VJ; Hargrave KD; Labadia M; Grozinger K; Skoog M; Wu JC; Shih CK; Eckner K; Hattox S; Adams J
    Science; 1990 Dec; 250(4986):1411-3. PubMed ID: 1701568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.
    Sardana VV; Emini EA; Gotlib L; Graham DJ; Lineberger DW; Long WJ; Schlabach AJ; Wolfgang JA; Condra JH
    J Biol Chem; 1992 Sep; 267(25):17526-30. PubMed ID: 1381350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding of a novel bisheteroarylpiperazine mediates inhibition of human immunodeficiency virus type 1 reverse transcriptase.
    Dueweke TJ; Kézdy FJ; Waszak GA; Deibel MR; Tarpley WG
    J Biol Chem; 1992 Jan; 267(1):27-30. PubMed ID: 1370445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxanilide derivative non-nucleoside inhibitors of HIV-1 reverse transcriptase interact with different mechanistic forms of the enzyme.
    Fletcher RS; Syed K; Mithani S; Dmitrienko GI; Parniak MA
    Biochemistry; 1995 Apr; 34(13):4346-53. PubMed ID: 7535561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.
    Koup RA; Merluzzi VJ; Hargrave KD; Adams J; Grozinger K; Eckner RJ; Sullivan JL
    J Infect Dis; 1991 May; 163(5):966-70. PubMed ID: 1708400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nevirapine alters the cleavage specificity of ribonuclease H of human immunodeficiency virus 1 reverse transcriptase.
    Palaniappan C; Fay PJ; Bambara RA
    J Biol Chem; 1995 Mar; 270(9):4861-9. PubMed ID: 7533167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors.
    Spence RA; Kati WM; Anderson KS; Johnson KA
    Science; 1995 Feb; 267(5200):988-93. PubMed ID: 7532321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.